Botulinum Toxin Type A Enhances the Outcome of Fractional Resurfacing of the Cheek
November 2007 | Volume 6 | Issue 11 | Case Reports | 1151 | Copyright © November 2007
Kenneth Beer MD, Jill Waibel MD
Fractional resurfacing and fractionally ablative (CO2) resurfacing have become increasingly popular in recent years. They
hold the promise of delivering skin rejuvenation with fewer risks and less downtime than traditional ablative resurfacing.
Despite the popularity of the procedures and the trend toward synergistic activity in aesthetic dermatology, there is little
documentation regarding the use of botulinum toxins and fractional resurfacing for the midface. This report discusses the
use of botulinum toxin type A and fractional resurfacing for the cheek area. Although it is a limited, single case report,
it provides insight into the potential for this combination and may serve as a stimulus for a large, well-controlled study to
evaluate the use of toxins in this and similar areas.